SEC Mandates Activist Investors Disclose Clients in Regulatory Filings

Activist investors in the U.S. must now disclose the identities of their clients in certain regulatory filings, according to new guidance from the Securities and Exchange Commission. The move represents a significant shift toward greater transparency, potentially unsettling hedge funds that have long protected the anonymity of their financial backers.

New Interpretations Clarify Rules

The SEC issued the unexpected update through its Corporate Finance Interpretations, clarifying its stance on disclosure requirements for 13D filings and proxy statements. The guidance signals the regulator's increased interest in who is financing campaigns that push for strategic or board-level changes at public companies.

The updated interpretations specify that:

• The identities of investors in an entity, such as a special purpose vehicle (SPV) or "sidecar," formed to acquire a company's securities for an activist campaign must be disclosed (Question 110.09).
• Clients of a limited partnership are considered "participants" in a proxy contest to change board directors if they have invested more than $500 (Question 155.02).

Impact on Activist Investing

Ad

For years, activist hedge funds have prized secrecy, arguing that revealing their investors' identities could expose their strategies to copycats and diminish their competitive advantage. This new guidance directly challenges that practice, particularly as the use of SPVs to fund individual campaigns has grown more common.

Conversely, corporations targeted by activists have advocated for such transparency, stating that knowing the ultimate source of the funds is crucial for mounting a defense. The SEC's clarification provides these companies with a new level of insight into the financial backing of activist campaigns.

Context and Precedent

The SEC's move comes amid a busy first half of 2026 for shareholder activism, with firms like Elliott Investment Management and Ancora Alternatives launching campaigns at companies including Warner Bros Discovery and Devon Energy.

This development echoes a 2022 corporate governance battle where medical device firm Masimo Corp. amended its bylaws to force activist Politan Capital to disclose its limited partners. While the move sparked backlash from investors and Masimo later reversed the policy in 2023, it highlighted the growing tension between corporate boards and activist funds over investor anonymity.